glp 1 and immune system Beyond metabolic benefits: The underexplored immunomodulatory effects of -1/glucagon agonists GLP-1 | Summary
Description
Eli Lilly CEO David Ricks announces details of the Medicare GLP-1 bridge program, offering weight loss medications like Fondeo and Zepbound for $50 per month to 20 million eligible Medicare Part D patients starting July 1.

All patients with diabetes should have yearly eye exams

This narrative reviewaims to analyzecurrent findings on the beneficial and adverse ocular effects of GLP-1RAsuse, highlighting studies that elucidate the harmful causes, such as retinal microvascular dysregulation, inflammatory modulation, oxidative stress,osmotic dysregulation from sorbitol accumulation,and metabolic shifts

Provider-guided care in Oregon, Washington, and California

Heres how to check your coverage and save over $200 per month with SingleCare.

Oncology is the largest aggregate contributor to net growth in this forecast, with oncology spending reaching $187 bn by 2028
